FDA Approves Novel Pandemic Influenza Vaccine
FDA Approves Novel Pandemic Influenza Vaccine – Medscape – Feb 03, 2020. Megan Brooks The US Food and Drug Administration (FDA) has approved the first and only adjuvanted, cell-based pandemic vaccine to provide active immunization against the influenza A virus H5N1 strain. Influenza A (H5N1) monovalent vaccine, adjuvanted (Audenz, Seqirus) is for use in individuals aged 6 months and older. It’s designed […]
